Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment

Ann Intern Med. 2021 Mar;174(3):432. doi: 10.7326/L20-1456.

Authors

Eugene Brailovski¹, Richard B Kim², David Juurlink¹

Affiliations

¹ University of Toronto, Toronto, Ontario, Canada.
² University of Western Ontario, London, Ontario, Canada.

PMID: 33721527
DOI: 10.7326/L20-1456

No abstract available

Publication types

Comment

MeSH terms

Canagliflozin* / adverse effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Myotoxicity
Rosuvastatin Calcium / adverse effects

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Canagliflozin
Rosuvastatin Calcium